Oncimmune Share Price (ONC)

Https://www.outsourcing-pharma.com/Article/2024/04/23/oncimmune-ventures-into-age-related-disease-biomarker-research

23.04. MG at Proactive London."Martin Gouldstone, Oncimmune’s Chief Executive Officer, said: “As ageing-related diseases become more prevalent in society we believe that our ImmunoINSIGHTS technology can be instrumental in finding better diagnosis and treatment solutions for these diseases, while making clinical trials more efficient and productive. We are working closely with our partners in this area and I look forward to discussing the topic with world-leading experts later this month.”

"The company is already working with leading drug discovery companies on ageing-related research and has been approached by several global pharmaceutical companies about the use of its technology in this field."

Time will tell but I have observed this company for a while now and I guarantee that the upside potential for this is tremendous. The diagnostics market is poised to expand considerably over the coming years and with the diverse application of ONCimmune's service, I think deals will be closed. Many deals.

I also believe that the (Bio-) Pharma industry is awake and on the up again. Coming out of a prolonged period of under investment and bearish sentiment, there is a lot more activity on the M&A market. I can see a bull charging from the distance

Probably right. Someone certainly thinks there is reason to buy.

I bought a modest amount of shares at 21p. It was mainly based upon a sudden 12% jump and the RNS about meeting thresholds and declaring interest. There seemed to be few but chunky buys. There was zip on this board. I'm no expert at all and probably not a sensible reason to buy, but I have seen one of the board, Goold, mentioned in other articles. They seem like they have their heads screwed on and are serious people.